Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain
This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/18/9853 |
id |
doaj-6c39446141b84a2bab5c56e48a6ec1aa |
---|---|
record_format |
Article |
spelling |
doaj-6c39446141b84a2bab5c56e48a6ec1aa2021-09-26T00:20:49ZengMDPI AGInternational Journal of Environmental Research and Public Health1661-78271660-46012021-09-01189853985310.3390/ijerph18189853Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in SpainRuth Usó-Talamantes0Silvia González-de-Julián1Javier Díaz-Carnicero2Inmaculada Saurí-Ferrer3José Luis Trillo-Mata4Marc Carrasco-Pérez5Jorge Navarro-Pérez6José Luis Górriz7David Vivas-Consuelo8Josep Redón9Conselleria de Sanitat i Salut Pública, Generalitat Valenciana, 46010 Valencia, SpainResearch Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, SpainResearch Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, SpainINCLIVA Research Institute, 46010 Valencia, SpainHospital Valencia Clínico–Malvarrosa, 46010 Valencia, SpainBoehringer Ingelheim España S.A., 08174 Barcelona, SpainINCLIVA Research Institute, 46010 Valencia, SpainINCLIVA Research Institute, 46010 Valencia, SpainResearch Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, SpainINCLIVA Research Institute, 46010 Valencia, SpainThis study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clínico–La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population (<i>n</i> = 28,345) was 10.8% (mean age (SD) = 67.8 years (13.9); 51.5% male). Up to 14.935 patients (52.6%) had data on kidney function. According to the KDIGO classification, 66.2% of the patients were at low risk of CKD, 20.6% at moderately increased risk, 7.9% at high risk, and 5.2% at very high risk. The average healthcare costs associated with these four risk groups were EUR 3437, EUR 4936, EUR 5899 and EUR 7389, respectively. The large number of T2D patients with CKD in the early stages of the disease generated a significant increase in direct healthcare costs. The economic impact could be mitigated by early and comprehensive therapeutic approaches.https://www.mdpi.com/1660-4601/18/18/9853chronic kidney diseasetype 2 diabetescostshealthcare resourcesburden of careKDIGO classification |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ruth Usó-Talamantes Silvia González-de-Julián Javier Díaz-Carnicero Inmaculada Saurí-Ferrer José Luis Trillo-Mata Marc Carrasco-Pérez Jorge Navarro-Pérez José Luis Górriz David Vivas-Consuelo Josep Redón |
spellingShingle |
Ruth Usó-Talamantes Silvia González-de-Julián Javier Díaz-Carnicero Inmaculada Saurí-Ferrer José Luis Trillo-Mata Marc Carrasco-Pérez Jorge Navarro-Pérez José Luis Górriz David Vivas-Consuelo Josep Redón Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain International Journal of Environmental Research and Public Health chronic kidney disease type 2 diabetes costs healthcare resources burden of care KDIGO classification |
author_facet |
Ruth Usó-Talamantes Silvia González-de-Julián Javier Díaz-Carnicero Inmaculada Saurí-Ferrer José Luis Trillo-Mata Marc Carrasco-Pérez Jorge Navarro-Pérez José Luis Górriz David Vivas-Consuelo Josep Redón |
author_sort |
Ruth Usó-Talamantes |
title |
Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain |
title_short |
Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain |
title_full |
Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain |
title_fullStr |
Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain |
title_full_unstemmed |
Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain |
title_sort |
cost of type 2 diabetes patients with chronic kidney disease based on real-world data: an observational population-based study in spain |
publisher |
MDPI AG |
series |
International Journal of Environmental Research and Public Health |
issn |
1661-7827 1660-4601 |
publishDate |
2021-09-01 |
description |
This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clínico–La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population (<i>n</i> = 28,345) was 10.8% (mean age (SD) = 67.8 years (13.9); 51.5% male). Up to 14.935 patients (52.6%) had data on kidney function. According to the KDIGO classification, 66.2% of the patients were at low risk of CKD, 20.6% at moderately increased risk, 7.9% at high risk, and 5.2% at very high risk. The average healthcare costs associated with these four risk groups were EUR 3437, EUR 4936, EUR 5899 and EUR 7389, respectively. The large number of T2D patients with CKD in the early stages of the disease generated a significant increase in direct healthcare costs. The economic impact could be mitigated by early and comprehensive therapeutic approaches. |
topic |
chronic kidney disease type 2 diabetes costs healthcare resources burden of care KDIGO classification |
url |
https://www.mdpi.com/1660-4601/18/18/9853 |
work_keys_str_mv |
AT ruthusotalamantes costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT silviagonzalezdejulian costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT javierdiazcarnicero costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT inmaculadasauriferrer costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT joseluistrillomata costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT marccarrascoperez costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT jorgenavarroperez costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT joseluisgorriz costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT davidvivasconsuelo costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain AT josepredon costoftype2diabetespatientswithchronickidneydiseasebasedonrealworlddataanobservationalpopulationbasedstudyinspain |
_version_ |
1717366421084700672 |